Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD) (vol 8, e0310, 2024)

被引：1
|
作者：
Long, Q.
Luo, F.
Li, B.
Li, Z.
Chen, Z.
机构：
来源：
HEPATOLOGY COMMUNICATIONS | 2024年 / 8卷 / 07期
关键词：
D O I：
10.1097/HC9.0000000000000493
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease
    Long, Qichen
    Luo, Fengming
    Li, Binghui
    Li, Ziyang
    Guo, Zhe
    Chen, Zhiyang
    Wu, Weimin
    Hu, Min
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (03)
  • [2] Metabolic dysfunction-associated steatotic liver disease and gut microbiota
    Petryna, Vitalii
    JOURNAL OF HEPATOLOGY, 2024, 80 : S285 - S285
  • [3] Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Scarpellini, Emidio
    Scarcella, Marialaura
    Tack, Jan F.
    Scarlata, Giuseppe Guido Maria
    Zanetti, Michela
    Abenavoli, Ludovico
    ANTIOXIDANTS, 2024, 13 (11)
  • [4] Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Hamamah, Sevag
    Iatcu, Oana C.
    Covasa, Mihai
    NUTRIENTS, 2025, 17 (01)
  • [5] ALTERED GUT VIRAL ECOLOGY IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Nzabarushimana, Etienne
    Kim, Hanseul
    Jensen, Jordan
    Shen, Jiaxian
    Nelson, Paul
    Thompson, Kelsey N.
    Chan, Andrew T.
    Hayete, Boris
    Huttenhower, Curtis
    Nguyen, Long H.
    GASTROENTEROLOGY, 2024, 166 (05) : S1539 - S1540
  • [6] Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Zazueta, Alejandra
    Valenzuela-Perez, Lucia
    Ortiz-Lopez, Nicolas
    Pinto-Leon, Araceli
    Torres, Veronica
    Guinez, Danette
    Aliaga, Nicolas
    Merino, Pablo
    Sandoval, Alexandra
    Covarrubias, Natalia
    Perez de Arce, Edith
    Cattaneo, Maximo
    Urzua, Alvaro
    Roblero, Juan Pablo
    Poniachik, Jaime
    Gotteland, Martin
    Magne, Fabien
    Beltran, Caroll Jenny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [7] Evolutionary aspects of metabolic dysfunction-associated steatotic liver disease (MASLD)
    Geier, Andreas
    Schiffels, Stephan
    Krawczyk, Marcin
    GASTROENTEROLOGIE, 2025,
  • [8] USEFULNESS OF SERUM MICRORNAS AS BIOMARKERS FOR PEDIATRIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Blakley, Caroline
    Nelson, Benjamin
    Qarooni, Shatha
    Lee, Wai Han
    Tryggestad, Jeanie
    Short, Kevin
    Palle, Sirish Kumar
    HEPATOLOGY, 2024, 80 : S626 - S626
  • [9] NAD metabolic therapy in metabolic dysfunction-associated steatotic liver disease: Possible roles of gut microbiota
    Lu, Xinyi
    Yang, Rui
    Chen, Yu
    Chen, Daozhen
    ISCIENCE, 2024, 27 (03)
  • [10] Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Liu, Huan
    Yerevanian, Armen
    Westerhoff, Maria
    Hastings, Margaret H.
    Guerra, Justin Ralph Baldovino
    Zhao, Meng
    Svensson, Katrin J.
    Cai, Bishuang
    Soukas, Alexander A.
    Rosenzweig, Anthony
    DIABETES, 2024, 73 (02) : 260 - 279
12345